Canada markets open in 7 minutes

Biogen Inc. (BIIB)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
213.57+1.64 (+0.77%)
At close: 04:00PM EDT
213.50 -0.07 (-0.03%)
Pre-Market: 09:06AM EDT
Full screen
Trade prices are not sourced from all markets
Previous Close211.93
Bid210.81 x 1000
Ask215.28 x 1200
Day's Range208.13 - 213.68
52 Week Range187.16 - 372.12
Avg. Volume1,108,848
Market Cap31.278B
Beta (5Y Monthly)0.42
PE Ratio (TTM)21.86
EPS (TTM)9.77
Earnings DateJul 20, 2022 - Jul 25, 2022
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est238.74
  • News Direct

    Biogen Celebrates 20 Years of Caring Deeply

    Armany is a rising junior at Northeastern University majoring in electrical and computer engineering who developed a passion for science during his time as a Biogen Community Lab student and as a R...

  • Business Wire

    Biogen and Happify Health Collaborate to Support Multiple Sclerosis Patients on Digital Platform

    CAMBRIDGE, Mass. & NEW YORK, June 22, 2022--Biogen (NASDAQ:BIIB) and Happify Health (, the Intelligent Healing Company™, today announced a collaboration to provide a digital solution for patient education and engagement, powered by artificial intelligence (AI), to support people living with multiple sclerosis (MS). Through this collaboration, Biogen and Happify Health will help people with MS manage their care journey, improve their wellbeing, learn about treatment options,

  • Zacks

    Ionis (IONS), AstraZeneca's Amyloidosis Drug Meets Study Goals

    Ionis (IONS), along with partner AstraZeneca, reports positive data from a phase III study, which is evaluating eplontersen in hereditary transthyretin-mediated amyloid polyneuropathy (ATTRv-PN).